4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors

Published:2020-05 Issue:10 Volume:30 Page:127109
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

He Xingrui,Gao Yuan,Hui Zi,Shen Guodong,Wang Shuo,Xie Tian,Ye Xiang-Yang^ORCID

Funder

National Natural Science Foundation of China

Hangzhou Normal University

Natural Science Foundation of Shandong Province

Zhejiang University of Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference57 articles.

1. Cancer epigenetics: linking basic biology to clinical medicine;Tsai;Cell Res,2011

2. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy;Feng;Trends Cell Biol,2015

3. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications;Serrano-Gomez;Mol Cancer,2016

4. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1;Shi;Cell,2004

5. Advances toward LSD1 inhibitors for cancer therapy;Fu;Future Med Chem,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Quinquennial Review of Potent LSD1 Inhibitors Explored for the Treatment of Different Cancers, with Special Focus on SAR Studies;Current Medicinal Chemistry;2024-01

2. Anticancer therapeutic potential of benzofuran scaffolds;RSC Advances;2023

3. Role of Lysine-specific Demethylase 1 and Its Small Molecule Inhibitors in Glioblastoma Multiforme Therapy;Anti-Cancer Agents in Medicinal Chemistry;2022-09-14

4. LSD1 inhibitors for anticancer therapy: a patent review (2017-present);Expert Opinion on Therapeutic Patents;2022-08-09

5. Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present);European Journal of Medicinal Chemistry;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3